Financials

News Ideas Minds Forecast

RGO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Regeneron Pharmaceuticals Inc.

Total assets of RGO for Q1 24 is 31.85 B EUR, 6.12% more than the previous Q4 23. And total liabilities increased by 5.45% in Q1 24 to 6.84 B EUR.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—